These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 15030329)

  • 21. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression.
    Lokeshwar VB; Lokeshwar BL; Pham HT; Block NL
    Cancer Res; 1996 Feb; 56(3):651-7. PubMed ID: 8564986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated hyaluronan concentration without hyaluronidase activation in malignant epithelial ovarian tumors.
    Hiltunen EL; Anttila M; Kultti A; Ropponen K; Penttinen J; Yliskoski M; Kuronen AT; Juhola M; Tammi R; Tammi M; Kosma VM
    Cancer Res; 2002 Nov; 62(22):6410-3. PubMed ID: 12438225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis.
    Martin DC; Atmuri V; Hemming RJ; Farley J; Mort JS; Byers S; Hombach-Klonisch S; Csoka AB; Stern R; Triggs-Raine BL
    Hum Mol Genet; 2008 Jul; 17(13):1904-15. PubMed ID: 18344557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced activity of serum and urinary hyaluronidases in streptozotocin-induced diabetic Wistar and GK rats.
    Ikegami-Kawai M; Okuda R; Nemoto T; Inada N; Takahashi T
    Glycobiology; 2004 Jan; 14(1):65-72. PubMed ID: 14551218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum hyaluronic acid during lamivudine treatment in chronic hepatitis B.
    Grzeszczuk A; Prokopowicz D
    Rocz Akad Med Bialymst; 2004; 49():275-9. PubMed ID: 15631357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis.
    Yanaba K; Yoshizaki A; Muroi E; Hara T; Ogawa F; Usui A; Hasegawa M; Fujimoto M; Takehara K; Sato S
    J Rheumatol; 2009 Aug; 36(8):1657-62. PubMed ID: 19531747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronates in developing skeletal tissues.
    Nathanson MA
    Clin Orthop Relat Res; 1990 Feb; (251):275-89. PubMed ID: 2403874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer.
    Udabage L; Brownlee GR; Nilsson SK; Brown TJ
    Exp Cell Res; 2005 Oct; 310(1):205-17. PubMed ID: 16125700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of hyaluronan length in a hyaladherin-based assay for hyaluronan.
    Courel MN; Maingonnat C; Tranchepain F; Deschrevel B; Vincent JC; Bertrand P; Delpech B
    Anal Biochem; 2002 Mar; 302(2):285-90. PubMed ID: 11878809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Increased levels of circulating hyaluronate in the sera of patients with rheumatoid arthritis with special reference to joint destruction].
    Yamada N; Uzuki M; Rikimaru A; Sakurai M; Sawai T
    Ryumachi; 1994 Aug; 34(4):752-60. PubMed ID: 7974026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1.
    Lokeshwar VB; Young MJ; Goudarzi G; Iida N; Yudin AI; Cherr GN; Selzer MG
    Cancer Res; 1999 Sep; 59(17):4464-70. PubMed ID: 10485499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human hyaluronidase Hyal-1: insect cells versus Escherichia coli as expression system and identification of low molecular weight inhibitors.
    Hofinger ES; Spickenreither M; Oschmann J; Bernhardt G; Rudolph R; Buschauer A
    Glycobiology; 2007 Apr; 17(4):444-53. PubMed ID: 17227790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum hyaluronic acid levels are elevated in arthritis patients, but normal and not associated with clinical data in patients with fibromyalgia syndrome.
    Werle E; Jäkel HP; Müller A; Fischer H; Fiehn W; Eich W
    Clin Lab; 2005; 51(1-2):11-9. PubMed ID: 15719700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyaluronan in human acute and chronic dermal wounds.
    Dechert TA; Ducale AE; Ward SI; Yager DR
    Wound Repair Regen; 2006; 14(3):252-8. PubMed ID: 16808803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis.
    Asano Y; Ihn H; Kubo M; Jinnin M; Mimura Y; Ashida R; Tamaki K
    Rheumatology (Oxford); 2006 Mar; 45(3):303-7. PubMed ID: 16278285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis.
    Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K
    Br J Dermatol; 2004 Oct; 151(4):803-8. PubMed ID: 15491420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma.
    Tomimura S; Ogawa F; Iwata Y; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    J Dermatol Sci; 2008 Oct; 52(1):47-54. PubMed ID: 18565735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast growth factor-2 regulates the synthesis of hyaluronan by human periodontal ligament cells.
    Shimabukuro Y; Ichikawa T; Takayama S; Yamada S; Takedachi M; Terakura M; Hashikawa T; Murakami S
    J Cell Physiol; 2005 Jun; 203(3):557-63. PubMed ID: 15573376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Komura K; Yanaba K; Hayakawa I; Matsushita T; Takehara K
    Rheumatology (Oxford); 2004 Oct; 43(10):1261-6. PubMed ID: 15266059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Devising a pathway for hyaluronan catabolism: are we there yet?
    Stern R
    Glycobiology; 2003 Dec; 13(12):105R-115R. PubMed ID: 14514708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.